These two guys want to update you all to how much

1-TDC has helped them with their ARTHRITIS.

Dr. Blake and Dr. Louie havefound theat 1-TDC has helped cases where acupuncture, homeopathy, Gemmotherapy and nutrition were no longer helping. It is because of the research and his personal observations, he has been  recommending to clients and readers to consider 1-TDC for their pets’ joint health and for their own health.

Make a difference and share this with YOUR VETERINARIAN so that all of the animals in their care, can have the benefit of this truly amazing product.

The use of 1-TDC for gum health  has been well documented by the research they have done in humans and animals. The anti-inflammatory properties of 1-TDC are well documented.. These two properties of1-TDC
create a healthier environment in the oral cavity. Palatability is excellent, which lends itself to optimum compliance. This unique product has no competition in veterinary medicine for providing gum health..

To order any of these amazing products, click here http://www.thepetwhisperer.com/products/tdc

ORDERS WILL ONLY BE SHIPPED TO ADDRESSES IN THE UNITED STATES

Dr. BLake and Dr. Louie are encouraging all pet caregivers to tell their veterinarians about this wonderful product. Please have them use the contact information below to help them learn more about this amazing product.

If you are a veterinarian and would like to offer this product line to your clients, EMAIL Olivier at info@EliteScience.net or call  1-888.492.5965 and use the code ES537 when you talk to them to get a special offer on your first order for being referred by Dr. Blake

Healthy oils (omega 3, fish and flax oil etc) are considered “healthy” because of their ability to limit inflammation. 1-TDC works in much the same way as these oils. However based on clinical trial results, it
appears that 1-TDC simply has a much greater ability to lubricate cell membranes. The clinical efficacy of 1-TDC has been published in such esteemed journals as the Journal of Rheumatology,  the Journal of Strength Conditioning and Research and the Journal of Periodontolgy.

The cellular pathway instrumental in the efficacy of 1-TDC

 

It has been shown that 1-TDC reduces joint and muscular discomfort within 30 minutes of topical application and within 14 days of oral consumption.Radio tracer label data and ligand binding assays support the hypothesis that 1-TDC+ interacts with membrane receptors.. To support this hypothesis dual-label tracer data show the appearance of the labeled components of 1-TDC in the phospholipid fractions. The greatest amount of the label was found in the phospholipid fractions of liver homogenates (e.g. microsomes) and white blood cell microsomes. Binding assay studies have been conducted. In these in vitro studies..

I have found this is be an effective supplement for helping with acute or chronic joint inflammation and for gum health. I have found 1 per 10 pounds the first month and then 1 per 20 pounds from then on. I have also found that some patients need less to get the effect we need and also I have found you can dose every 2 to 3 days once my patients have been stabilized. Have seen increase in energy, endurance and mobility using this simple Etherified Fatty Acid. GAIT2006 & 2008

Glucosamine Arthritis Intervention Trial
New England Journal of Medicine 2006: Volume 354:795-808 what is the Glucosamine/ chondroitin Arthritis Intervention Trial (GAIT)?

GAIT is the first large-scale, multicenter clinical trial in the United States to test the effects of the dietary supplements glucosamine hydrochloride (glucosamine) and sodium chondroitin sulfate (chondroitin
sulfate) for the treatment of knee osteoarthritis. The study tested whether glucosamine and chondroitin sulfate used separately or in combination reduced pain in participants with knee osteoarthritis.
In GAIT, participants were randomly assigned to one of five treatment groups: (1) glucosamine alone, (2) chondroitin sulfate alone, (3) glucosamine and chondroitin sulfate in combination, (4) celecoxib, or (5) a placebo. New England Journal of Medicine 2006: Volume 354:795-808 what is the Glucosamine/ chondroitin Arthritis Intervention Trial (GAIT)?

GAIT is the first large-scale, multicenter clinical trial in the United States to test the effects of the dietary supplements glucosamine hydrochloride (glucosamine) and sodium chondroitin sulfate (chondroitin
sulfate) for the treatment of knee osteoarthritis. The study tested whether glucosamine and chondroitin sulfate used separately or in combination reduced pain in participants with knee osteoarthritis.
In GAIT, participants were randomly assigned to one of five treatment groups: (1) glucosamine alone, (2) chondroitin sulfate alone, (3) glucosamine and chondroitin sulfate in combination, (4) celecoxib, or (5) a placebo.

Key Results